348 related articles for article (PubMed ID: 23585873)
1. Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy.
Pripuzova NS; Gmyl LV; Romanova LIu; Tereshkina NV; Rogova YV; Terekhina LL; Kozlovskaya LI; Vorovitch MF; Grishina KG; Timofeev AV; Karganova GG
PLoS One; 2013; 8(4):e61094. PubMed ID: 23585873
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
Chidumayo NN; Yoshii K; Kariwa H
Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
[TBL] [Abstract][Full Text] [Related]
4. Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin.
Chernokhaeva LL; Rogova YV; Vorovitch MF; Romanova LIu; Kozlovskaya LI; Maikova GB; Kholodilov IS; Karganova GG
Vaccine; 2016 Apr; 34(20):2354-61. PubMed ID: 27013433
[TBL] [Abstract][Full Text] [Related]
5. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
6. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines.
Ruzek D; Avšič Županc T; Borde J; Chrdle A; Eyer L; Karganova G; Kholodilov I; Knap N; Kozlovskaya L; Matveev A; Miller AD; Osolodkin DI; Överby AK; Tikunova N; Tkachev S; Zajkowska J
Antiviral Res; 2019 Apr; 164():23-51. PubMed ID: 30710567
[TBL] [Abstract][Full Text] [Related]
7. Single-dose vaccine against tick-borne encephalitis.
Rumyantsev AA; Goncalvez AP; Giel-Moloney M; Catalan J; Liu Y; Gao QS; Almond J; Kleanthous H; Pugachev KV
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13103-8. PubMed ID: 23858441
[TBL] [Abstract][Full Text] [Related]
8. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
9. Ability of inactivated vaccines based on far-eastern tick-borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients.
Maikova GB; Chernokhaeva LL; Rogova YV; Kozlovskaya LI; Kholodilov IS; Romanenko VV; Esyunina MS; Ankudinova AA; Kilyachina AS; Vorovitch MF; Karganova GG
J Med Virol; 2019 Feb; 91(2):190-200. PubMed ID: 30204244
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
[TBL] [Abstract][Full Text] [Related]
11. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
Orlinger KK; Hofmeister Y; Fritz R; Holzer GW; Falkner FG; Unger B; Loew-Baselli A; Poellabauer EM; Ehrlich HJ; Barrett PN; Kreil TR
J Infect Dis; 2011 Jun; 203(11):1556-64. PubMed ID: 21592984
[TBL] [Abstract][Full Text] [Related]
12. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
[TBL] [Abstract][Full Text] [Related]
13. Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use.
Salát J; Formanová P; Huňady M; Eyer L; Palus M; Ruzek D
Vaccine; 2018 Nov; 36(48):7257-7261. PubMed ID: 30337175
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and immunogenicity of a veterinary vaccine candidate against tick-borne encephalitis in dogs.
Salat J; Hunady M; Svoboda P; Strelcova L; Strakova P; Fortova A; Palus M; Ruzek D
Vaccine; 2023 Oct; 41(42):6150-6155. PubMed ID: 37716828
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of tick-borne encephalitis vaccination in Latvia, 2018-2020: an observational study.
Zavadska D; Freimane Z; Karelis G; Ermina I; Harper LR; Bender C; Zhang P; Angulo FJ; Erber W; Bormane A; Gutmane E; Litauniece ZA; Tihonovs J; Griskevica A; Madhava H; Jodar L
Clin Microbiol Infect; 2023 Nov; 29(11):1443-1448. PubMed ID: 37422077
[TBL] [Abstract][Full Text] [Related]
17. TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.
Zent O; Schwarz TF; Plentz A; Banzhoff A; Jilg W
Int J Med Microbiol; 2004 Apr; 293 Suppl 37():134-8. PubMed ID: 15146995
[TBL] [Abstract][Full Text] [Related]
18. Revealing new tick-borne encephalitis virus foci by screening antibodies in sheep milk.
Wallenhammar A; Lindqvist R; Asghar N; Gunaltay S; Fredlund H; Davidsson Å; Andersson S; Överby AK; Johansson M
Parasit Vectors; 2020 Apr; 13(1):185. PubMed ID: 32268924
[TBL] [Abstract][Full Text] [Related]
19. A systematic literature review of the effectiveness of tick-borne encephalitis vaccines in Europe.
Angulo FJ; Zhang P; Halsby K; Kelly P; Pilz A; Madhava H; Moïsi JC; Jodar L
Vaccine; 2023 Nov; 41(47):6914-6921. PubMed ID: 37858450
[TBL] [Abstract][Full Text] [Related]
20. Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence.
Beran J; Lattanzi M; Xie F; Moraschini L; Galgani I
Vaccine; 2019 Jul; 37(32):4623-4629. PubMed ID: 29397225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
